Spotlight Innovation Inc (AEXP) financial statements (2020 and earlier)

Company profile

Business Address 11147 AURORA AVENUE
URBANDALE, IA 50322
State of Incorp. NV
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments000000
Cash and cash equivalents000000
Inventory, net of allowances, customer advances and progress billings0   
Inventory0     
Prepaid expense000  
Other undisclosed current assets 1 00 
Total current assets:020000
Noncurrent Assets
Property, plant and equipment0000  
Other undisclosed noncurrent assets77770 
Total noncurrent assets:77770 
TOTAL ASSETS:797700
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:111100
Accounts payable10000 
Accrued liabilities11100 
Employee-related liabilities     0
Settlement liabilities 0  
Other undisclosed accounts payable and accrued liabilities     0
Debt10200 
Due to related parties000   
Other undisclosed current liabilities0524 1
Total current liabilities:365511
Noncurrent Liabilities
Long-term debt and lease obligation1     
Long-term debt, excluding current maturities1     
Other undisclosed noncurrent liabilities31 (0)  
Total noncurrent liabilities:41 (0)  
Other undisclosed liabilities    5 
Total liabilities:775461
Stockholders' equity
Stockholders' equity attributable to parent, including:(2)(1)03(6)(1)
Common stock000000
Additional paid in capital4034191117
Retained earnings (accumulated deficit)42(35)(19)(11) (0)
Other undisclosed stockholders' equity attributable to parent(83)  2(7)(8)
Stockholders' equity attributable to noncontrolling interest2322  
Other undisclosed stockholders' equity   (2)  
Total stockholders' equity:1123(6)(1)
TOTAL LIABILITIES AND EQUITY:797700

Income statement (P&L) ($ in millions)

12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenues00    
Financial services revenue0     
Other income00 
Cost of revenue
(Cost of Goods and Services Sold)
(0)     
Gross profit:(0)0    
Operating expenses(5)(7)(5)(1)(6)(1)
Other undisclosed operating loss (0)    
Operating loss:(5)(7)(5)(1)(6)(1)
Nonoperating expense(2)(10)(3)(2)(1)(0)
Interest and debt expense(1)(3)(2)(2)(1)(0)
Loss from continuing operations before income taxes:(8)(20)(10)(6)(8)(1)
Other undisclosed income from continuing operations82010   
Income (loss) from continuing operations:000(6)(8)(1)
Income from discontinued operations 0    
Income (loss) before gain (loss) on sale of properties:000(6)(8)(1)
Other undisclosed net income (loss)(6)(17)(8) 1 
Net loss:(6)(17)(8)(6)(7)(1)
Net income attributable to noncontrolling interest   0  
Other undisclosed net income (loss) attributable to parent(0)(0)(0)2 0
Net loss available to common stockholders, diluted:(6)(17)(8)(4)(7)(1)

Comprehensive Income ($ in millions)

12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net loss:(6)(17)(8)(6)(7)(1)
Comprehensive loss:(6)(17)(8)(6)(7)(1)
Comprehensive loss, net of tax, attributable to noncontrolling interest   (0)  
Comprehensive loss, net of tax, attributable to parent:(6)(17)(8)(6)(7)(1)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: